Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro/ GentleMax Pro Plus

NCT04993066 is registered in ClinicalTrials.gov with Candela Corporation as lead sponsor.

NCT NCT04993066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04993066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro/ GentleMax Pro Plus
Lead sponsor
Candela Corporation
Phase
Not applicable
Overall status
Completed
Start date
November 12, 2020
Completion date
April 27, 2023
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne, onychomycosis, pigmented lesions, pseudofolliculitis barbae, unwanted hair, vascular lesion, wrinkle